Evidence map›Paper›PMID 30813350›Full record

ArticleNutrients2019

Inhibition of Tumor Growth by Dietary Indole-3-Carbinol in a Prostate Cancer Xenograft Model May Be Associated with Disrupted Gut Microbial Interactions.

Yanbei Wu, Robert W Li, Haiqiu Huang, Arnetta Fletcher, Lu Yu, Quynhchi Pham, Liangli Yu, Qiang He, Thomas T Y Wang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Systemic Review of Clot Retraction Modulators.International journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Gut microbiome: a novel preventive and therapeutic target for prostatic disease.Frontiers in cellular and infection microbiology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. The Interaction Between the Microbiome and Tumors.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yanbei WuCollege of Light Industry, Textile and Food Engineering, Sichuan University, Chengdu 610065, China. yanbeiwu@hotmail.com.
Robert W LiAnimal Parasitic Diseases Laboratory, USDA-ARS, Beltsville, MD 20705, USA. robert.li@ars.usda.gov.
Haiqiu HuangDiet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, USDA-ARS, Beltsville, MD 20705, USA. tennisqiu@gmail.com.ORCID 0000-0003-1543-3901
Arnetta FletcherDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA. afletche@shepherd.edu.
Lu YuDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA. yulu0640514@gmail.com.
Quynhchi PhamDiet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, USDA-ARS, Beltsville, MD 20705, USA. quynhchi.pham@ars.usda.gov.
Liangli YuDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA. lyu5@umd.edu.
Qiang HeCollege of Light Industry, Textile and Food Engineering, Sichuan University, Chengdu 610065, China. heq361@163.com.
Thomas T Y WangDiet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, USDA-ARS, Beltsville, MD 20705, USA. Tom.Wang@ars.usda.gov.
Beltsville Human Nutrition Research Center · USSichuan University · CNUniversity of Maryland, College Park · USShepherd University · US

Funding

U.S. Department of Agriculture #8040-51530-056-00D
6 · The paper itself

Abstract

Accumulated evidence suggests that the cruciferous vegetables-derived compound indole-3-carbinol (I3C) may protect against prostate cancer, but the precise mechanisms underlying its action remain unclear. This study aimed to verify the hypothesis that the beneficial effect of dietary I3C may be due to its modulatory effect on the gut microbiome of mice. Athymic nude mice (5⁻7 weeks old, male, Balb c/c nu/nu) with established tumor xenografts were fed a basal diet (AIN-93) with or without 1 µmoles I3C/g for 9 weeks. The effects of dietary I3C on gut microbial composition and microbial species interactions were then examined by 16s rRNA gene-based sequencing and co-occurrence network analysis. I3C supplementation significantly inhibited tumor growth (

Indexed as

Animal FeedAnimalsCecumDietDNAFecesGastrointestinal MicrobiomeIndolesMaleMiceMice, Inbred BALB CMice, NudeNeoplasms, ExperimentalDNAindole-3-carbinolIndolesco-occurrence networkgut microbiotaindole-3-carbinolmicrobial interactionsprostate cancer

Identifiers

PMID30813350
PMCPMC6413210
OpenAlexW2917278916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.